Hemostasis in Liver Cirrhosis and Hepatocellular Cancer
Recruiting
Observational Study
Hemostasis in Decompensated Liver Cirrhosis
Inflammation in Decompensated Liver Cirrhosis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- Region Stockholm · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Evaluating hemostasis in decompensated liver cirrhosis with novel hemostatic assays.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with decompensated liver cirrhosis
* 18 years or older.
* Healthy individuals 18 years or older will serve as controls.
Exclusion Criteria:
* • Extrahepatic malignancy or recurrence of such within the last year.
* Diagnosis of non-cirrhotic coagulopathy, coagulat…
Contacts